Pfizer Halts Lyrica Epilepsy Study - WSJ.com

Links shared publicly online about this topic.

0
total visits

Pfizer Halts Lyrica Epilepsy Study - WSJ.com

Pfizer terminated a clinical trial of its drug Lyrica because interim results suggested the drug was effective as a stand-alone treatment for seizures in epilepsy patients.

View full resource at online.wsj.com

Tags: Seizure, Seizure Medication, Epilepsy, Fibromyalgia Medication, Neuropathic Pain Medication, Lyrica, Pfizer, Epilepsy Medication

Most Recently Shared on October 6, 2011 at 2:15 pm By:

Yuri Maricich MD MBA

Pfizer Halts Lyrica Epilepsy Study http://t.co/jQJ0Ri5R via @WSJ #lifesciences #calcium #in #innovation #pharma

6 months ago...

Retweet

Favorite

Pfizer Lyrica Phase 3 study on Central Neuropathic Pain meets primary endpoint

news-medical.net — “Pfizer Inc. announced today that top-line results for Lyrica Study A0081107 - Central Neuropathic Pain Following Spinal Cord Injury - demonstrated that the study met its primary endpoint: positive efficacy in reducing Central Neuropathic Pain following Spinal Cord Injury with Lyrica compared to placebo.” View full resource at news-medical.net